Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchProton Pump InhibitorsPPIs (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching

Jul 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Severe case, ICU, mecha.. -79% Improvement Relative Risk Severe case, oxygen, ICU.. -63% Case 10% Proton Pump Inhibitors  Lee et al.  Prophylaxis Is prophylaxis with proton pump inhibitors beneficial for COVID-19? PSM retrospective 27,746 patients in South Korea (Jan - May 2020) Higher severe cases with proton pump inhibitors (p=0.0086) c19early.org Lee et al., Gut, July 2020 FavorsPPIs Favorscontrol 0 0.5 1 1.5 2+
PPIs for COVID-19
1st treatment shown to increase risk in September 2020, now with p = 0.000000048 from 40 studies.
5,500+ studies for 119 treatments. c19early.org
PSM retrospective 132,316 patients in South Korea, showing significantly higher risk of severe COVID-19 with PPI use, but no significant difference in cases.
risk of severe case, 79.0% higher, OR 1.79, p = 0.009, treatment 267, control 267, adjusted per study, ICU, mechanical ventilation, death, propensity score matching, multivariable, RR approximated with OR.
risk of severe case, 63.0% higher, OR 1.63, p = 0.03, treatment 267, control 267, adjusted per study, oxygen, ICU, mechanical ventilation, death, propensity score matching, multivariable, RR approximated with OR.
risk of case, 10.0% lower, OR 0.90, p = 0.11, treatment 13,873, control 13,873, adjusted per study, propensity score matching, multivariable, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Lee et al., 30 Jul 2020, retrospective, South Korea, peer-reviewed, 12 authors, study period 1 January, 2020 - 15 May, 2020.
This PaperPPIsAll
DOI record: { "DOI": "10.1136/gutjnl-2020-322248", "ISSN": [ "0017-5749", "1468-3288" ], "URL": "http://dx.doi.org/10.1136/gutjnl-2020-322248", "abstract": "<jats:sec><jats:title>Objective</jats:title><jats:p>The adverse effects of proton pump inhibitors (PPIs) have been documented for pneumonia; however, there is no consensus regarding whether the use of PPIs might be harmful regarding the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In this regard, we aimed to measure the potential associations of the current use of PPIs with the infection rates of COVID-19 among patients who underwent SARS-CoV-2 testing.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Data were derived from a Korean nationwide cohort study with propensity score matching. We included 132 316 patients older than 18 years who tested for SARS-CoV-2 between 1 January and 15 May 2020. Endpoints were SARS-CoV-2 positivity (primary) and severe clinical outcomes of COVID-19 (secondary: admission to intensive care unit, administration of invasive ventilation or death).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In the entire cohort, there were 111 911 non-users, 14 163 current PPI users and 6242 past PPI users. After propensity score matching, the SARS-CoV-2 test positivity rate was not associated with the current or past use of PPIs. Among patients with confirmed COVID-19, the current use of PPIs conferred a 79% greater risk of severe clinical outcomes of COVID-19, while the relationship with the past use of PPIs remained insignificant. Current PPI use starting within the previous 30 days was associated with a 90% increased risk of severe clinical outcomes of COVID-19.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Patients taking PPIs are at increased risk for severe clinical outcomes of COVID-19 but not susceptible to SARS-CoV-2 infection. This suggests that physicians need to assess benefit–risk assessments in the management of acid-related diseases amid the COVID-19 pandemic.</jats:p></jats:sec>", "alternative-id": [ "10.1136/gutjnl-2020-322248" ], "author": [ { "affiliation": [], "family": "Lee", "given": "Seung Won", "sequence": "first" }, { "affiliation": [], "family": "Ha", "given": "Eun Kyo", "sequence": "additional" }, { "affiliation": [], "family": "Yeniova", "given": "Abdullah Özgür", "sequence": "additional" }, { "affiliation": [], "family": "Moon", "given": "Sung Yong", "sequence": "additional" }, { "affiliation": [], "family": "Kim", "given": "So Young", "sequence": "additional" }, { "affiliation": [], "family": "Koh", "given": "Hyun Yong", "sequence": "additional" }, { "affiliation": [], "family": "Yang", "given": "Jee Myung", "sequence": "additional" }, { "affiliation": [], "family": "Jeong", "given": "Su Jin", "sequence": "additional" }, { "affiliation": [], "family": "Moon", "given": "Sun Joon", "sequence": "additional" }, { "affiliation": [], "family": "Cho", "given": "Joo Young", "sequence": "additional" }, { "affiliation": [], "family": "Yoo", "given": "In Kyung", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-1628-9948", "affiliation": [], "authenticated-orcid": false, "family": "Yon", "given": "Dong Keon", "sequence": "additional" } ], "container-title": "Gut", "container-title-short": "Gut", "content-domain": { "crossmark-restriction": true, "domain": [ "bmj.com" ] }, "created": { "date-parts": [ [ 2020, 7, 30 ] ], "date-time": "2020-07-30T21:33:51Z", "timestamp": 1596144831000 }, "deposited": { "date-parts": [ [ 2022, 11, 5 ] ], "date-time": "2022-11-05T06:34:13Z", "timestamp": 1667630053000 }, "funder": [ { "DOI": "10.13039/501100003725", "award": [ "NRF2019R1G1A109977912" ], "doi-asserted-by": "crossref", "name": "National Research Foundation of Korea" } ], "indexed": { "date-parts": [ [ 2024, 7, 19 ] ], "date-time": "2024-07-19T14:27:08Z", "timestamp": 1721399228595 }, "is-referenced-by-count": 163, "issue": "1", "issued": { "date-parts": [ [ 2020, 7, 30 ] ] }, "journal-issue": { "issue": "1", "published-online": { "date-parts": [ [ 2020, 12, 9 ] ] }, "published-print": { "date-parts": [ [ 2021, 1 ] ] } }, "language": "en", "license": [ { "URL": "https://bmj.com/coronavirus/usage", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 7, 30 ] ], "date-time": "2020-07-30T00:00:00Z", "timestamp": 1596067200000 } } ], "link": [ { "URL": "https://syndication.highwire.org/content/doi/10.1136/gutjnl-2020-322248", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "239", "original-title": [], "page": "76-84", "prefix": "10.1136", "published": { "date-parts": [ [ 2020, 7, 30 ] ] }, "published-online": { "date-parts": [ [ 2020, 7, 30 ] ] }, "published-print": { "date-parts": [ [ 2021, 1 ] ] }, "publisher": "BMJ", "reference": [ { "DOI": "10.1001/jama.2020.5394", "article-title": "Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy", "author": "Grasselli", "doi-asserted-by": "crossref", "first-page": "1574", "journal-title": "JAMA", "key": "2021021905401457000_70.1.76.1", "volume": "323", "year": "2020" }, { "DOI": "10.3345/cep.2020.00493", "article-title": "Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; coronavirus Disease-19)", "author": "Park", "doi-asserted-by": "crossref", "first-page": "119", "journal-title": "Clin Exp Pediatr", "key": "2021021905401457000_70.1.76.2", "volume": "63", "year": "2020" }, { "DOI": "10.1183/13993003.00547-2020", "article-title": "Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis", "author": "Guan", "doi-asserted-by": "crossref", "first-page": "2000547", "journal-title": "Eur Respir J", "key": "2021021905401457000_70.1.76.3", "volume": "55", "year": "2020" }, { "DOI": "10.3345/cep.2020.00535", "article-title": "Epidemiology and clinical features of coronavirus disease 2019 in children", "author": "Choi", "doi-asserted-by": "crossref", "first-page": "125", "journal-title": "Clin Exp Pediatr", "key": "2021021905401457000_70.1.76.4", "volume": "63", "year": "2020" }, { "DOI": "10.1093/cid/ciaa415", "article-title": "Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission", "author": "Lighter", "doi-asserted-by": "crossref", "journal-title": "Clin Infect Dis", "key": "2021021905401457000_70.1.76.5", "year": "2020" }, { "DOI": "10.1158/2159-8290.CD-20-0422", "article-title": "Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak", "author": "Dai", "doi-asserted-by": "crossref", "first-page": "783", "journal-title": "Cancer Discov", "key": "2021021905401457000_70.1.76.6", "volume": "10", "year": "2020" }, { "DOI": "10.1016/S2352-3018(20)30111-9", "article-title": "COVID-19 in patients with HIV: clinical case series", "author": "Blanco", "doi-asserted-by": "crossref", "first-page": "e314", "journal-title": "Lancet HIV", "key": "2021021905401457000_70.1.76.7", "volume": "7", "year": "2020" }, { "DOI": "10.1056/NEJMoa2008975", "article-title": "Renin-Angiotensin-Aldosterone system inhibitors and risk of Covid-19", "author": "Reynolds", "doi-asserted-by": "crossref", "first-page": "2441", "journal-title": "N Engl J Med", "key": "2021021905401457000_70.1.76.8", "volume": "382", "year": "2020" }, { "DOI": "10.1136/bmj.l1580", "article-title": "Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study", "author": "Xie", "doi-asserted-by": "crossref", "first-page": "l1580", "journal-title": "BMJ", "key": "2021021905401457000_70.1.76.9", "volume": "365", "year": "2019" }, { "DOI": "10.1053/j.gastro.2019.10.023", "article-title": "Interpreting reported risks associated with use of proton pump inhibitors: residual confounding in a 10-year analysis of national ambulatory data", "author": "Ma", "doi-asserted-by": "crossref", "first-page": "780", "journal-title": "Gastroenterology", "key": "2021021905401457000_70.1.76.10", "volume": "158", "year": "2020" }, { "article-title": "Effects of daily treatment with acid suppressants for stress ulcer prophylaxis on risk of ventilator-associated events", "author": "Li", "first-page": "187", "journal-title": "Infect Control Hosp Epidemiol", "key": "2021021905401457000_70.1.76.11", "volume": "41", "year": "2020" }, { "article-title": "Incidence of cancer after asthma development: 2 independent population-based cohort studies", "author": "Woo", "journal-title": "J Allergy Clin Immunol", "key": "2021021905401457000_70.1.76.12", "year": "2020" }, { "DOI": "10.1111/pai.13233", "article-title": "Exposure to humidifier disinfectants is associated with upper and lower airway diseases", "author": "Yon", "doi-asserted-by": "crossref", "journal-title": "Pediatr Allergy Immunol", "key": "2021021905401457000_70.1.76.13", "year": "2020" }, { "DOI": "10.3345/cep.2019.01291", "article-title": "Ten-Year trends and prevalence of asthma, allergic rhinitis, and atopic dermatitis among the Korean population, 2008-2017", "author": "Ha", "doi-asserted-by": "crossref", "journal-title": "Clin Exp Pediatr", "key": "2021021905401457000_70.1.76.14", "volume": "63", "year": "2020" }, { "DOI": "10.1016/j.jaip.2019.05.015", "article-title": "Serum heavy metal levels are associated with asthma, allergic rhinitis, atopic dermatitis, allergic multimorbidity, and airflow obstruction", "author": "Koh", "doi-asserted-by": "crossref", "first-page": "2912", "journal-title": "J Allergy Clin Immunol Pract", "key": "2021021905401457000_70.1.76.15", "volume": "7", "year": "2019" }, { "article-title": "Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study", "author": "Jung", "journal-title": "Clin Infect Dis", "key": "2021021905401457000_70.1.76.16", "year": "2020" }, { "DOI": "10.7326/0003-4819-149-6-200809160-00005", "article-title": "Proton-Pump inhibitor use and the risk for community-acquired pneumonia", "author": "Sarkar", "doi-asserted-by": "crossref", "first-page": "391", "journal-title": "Ann Intern Med", "key": "2021021905401457000_70.1.76.17", "volume": "149", "year": "2008" }, { "key": "2021021905401457000_70.1.76.18", "unstructured": "Mehta N , Kalra A , Nowacki AS , et al . Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19). JAMA cardiology." }, { "DOI": "10.1001/jama.292.16.1955", "article-title": "Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs", "author": "Laheij", "doi-asserted-by": "crossref", "first-page": "1955", "journal-title": "JAMA", "key": "2021021905401457000_70.1.76.19", "volume": "292", "year": "2004" }, { "DOI": "10.3748/wjg.v23.i35.6500", "article-title": "Proton pump inhibitors therapy and risk of Clostridium difficile infection: systematic review and meta-analysis", "author": "Trifan", "doi-asserted-by": "crossref", "first-page": "6500", "journal-title": "World J Gastroenterol", "key": "2021021905401457000_70.1.76.20", "volume": "23", "year": "2017" }, { "DOI": "10.1080/14740338.2019.1577820", "article-title": "Proton pump inhibitors therapy and the risk of pneumonia: a systematic review and meta-analysis of randomized controlled trials and observational studies", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "163", "journal-title": "Expert Opin Drug Saf", "key": "2021021905401457000_70.1.76.21", "volume": "18", "year": "2019" }, { "DOI": "10.1124/pr.118.017129", "article-title": "Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure", "author": "Arendse", "doi-asserted-by": "crossref", "first-page": "539", "journal-title": "Pharmacol Rev", "key": "2021021905401457000_70.1.76.22", "volume": "71", "year": "2019" }, { "DOI": "10.1136/gutjnl-2020-321388", "article-title": "Faecal calprotectin indicates intestinal inflammation in COVID-19", "author": "Effenberger", "doi-asserted-by": "crossref", "first-page": "1543", "journal-title": "Gut", "key": "2021021905401457000_70.1.76.23", "volume": "69", "year": "2020" }, { "DOI": "10.1136/gutjnl-2020-320953", "article-title": "Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process", "author": "Zhang", "doi-asserted-by": "crossref", "first-page": "1010", "journal-title": "Gut", "key": "2021021905401457000_70.1.76.24", "volume": "69", "year": "2020" }, { "DOI": "10.1136/gutjnl-2020-321013", "article-title": "Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection", "author": "Lin", "doi-asserted-by": "crossref", "first-page": "997", "journal-title": "Gut", "key": "2021021905401457000_70.1.76.25", "volume": "69", "year": "2020" }, { "DOI": "10.1016/j.cell.2020.02.052", "article-title": "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor", "author": "Hoffmann", "doi-asserted-by": "crossref", "first-page": "271", "journal-title": "Cell", "key": "2021021905401457000_70.1.76.26", "volume": "181", "year": "2020" }, { "DOI": "10.1016/S2665-9913(20)30092-8", "article-title": "Preventing COVID-19-induced pneumonia with anticytokine therapy", "author": "Monteleone", "doi-asserted-by": "crossref", "first-page": "e255", "journal-title": "Lancet Rheumatol", "key": "2021021905401457000_70.1.76.27", "volume": "2", "year": "2020" }, { "DOI": "10.1126/sciadv.aao4966", "doi-asserted-by": "publisher", "key": "2021021905401457000_70.1.76.28" }, { "DOI": "10.1371/journal.pone.0128004", "article-title": "Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis", "author": "Lambert", "doi-asserted-by": "crossref", "journal-title": "PLoS One", "key": "2021021905401457000_70.1.76.29", "volume": "10", "year": "2015" }, { "DOI": "10.1586/ecp.12.20", "article-title": "Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis", "author": "Giuliano", "doi-asserted-by": "crossref", "first-page": "337", "journal-title": "Expert Rev Clin Pharmacol", "key": "2021021905401457000_70.1.76.30", "volume": "5", "year": "2012" }, { "DOI": "10.1016/j.jns.2019.02.041", "article-title": "Acid-suppressive medications and risk of pneumonia in acute stroke patients: a systematic review and meta-analysis", "author": "Marchina", "doi-asserted-by": "crossref", "first-page": "122", "journal-title": "J Neurol Sci", "key": "2021021905401457000_70.1.76.31", "volume": "400", "year": "2019" }, { "DOI": "10.1016/j.virusres.2020.198005", "article-title": "Co-Infection with respiratory pathogens among COVID-2019 cases", "author": "Zhu", "doi-asserted-by": "crossref", "journal-title": "Virus Res", "key": "2021021905401457000_70.1.76.32", "volume": "285", "year": "2020" }, { "DOI": "10.23876/j.krcp.2018.37.1.59", "article-title": "Association of proton pump inhibitor use with renal outcomes in patients with coronary artery disease", "author": "Cho", "doi-asserted-by": "crossref", "first-page": "59", "journal-title": "Kidney Res Clin Pract", "key": "2021021905401457000_70.1.76.33", "volume": "37", "year": "2018" }, { "DOI": "10.3343/alm.2020.40.5.351", "article-title": "Guidelines for laboratory diagnosis of coronavirus disease 2019 (COVID-19) in Korea", "author": "Hong", "doi-asserted-by": "crossref", "first-page": "351", "journal-title": "Ann Lab Med", "key": "2021021905401457000_70.1.76.34", "volume": "40", "year": "2020" }, { "DOI": "10.1046/j.1365-2036.2000.00840.x", "article-title": "CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole", "author": "Adachi", "doi-asserted-by": "crossref", "first-page": "1259", "journal-title": "Aliment Pharmacol Ther", "key": "2021021905401457000_70.1.76.35", "volume": "14", "year": "2000" }, { "DOI": "10.1016/j.sapharm.2005.12.001", "article-title": "Addressing the issue of channeling bias in observational studies with propensity scores analysis", "author": "Lobo", "doi-asserted-by": "crossref", "first-page": "143", "journal-title": "Res Social Adm Pharm", "key": "2021021905401457000_70.1.76.36", "volume": "2", "year": "2006" } ], "reference-count": 36, "references-count": 36, "relation": {}, "resource": { "primary": { "URL": "https://gut.bmj.com/lookup/doi/10.1136/gutjnl-2020-322248" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1136/crossmarkpolicy", "volume": "70" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit